Literature DB >> 15974910

Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Hong Zhang1, Bing Gong, Shumin Liu, Mauro Fa', Ipe Ninan, Agnieszka Staniszewski, Ottavio Arancio.   

Abstract

To search for potential mechanism that might alter synaptic transmission following Abeta increase we have examined the presynaptic component of transmitter release. As parameters of synaptic transmission that might underlie presynaptic mechanisms, we have used paired-pulse facilitation (PPF), post-tetanic potentiation (PTP), and synaptic fatigue (SF) at the connection between the hippocampal Schaffer-collateral pathway and CA1 pyramidal neurons in approximately 5 month old double transgenic mice overexpressing the mutated form of amyloid precursor protein (APPK670N, M671L) and presenilin 1 (PS1M146V). While the presynaptic mechanisms of PPF and PTP were not compromised in the APP/PS1 mice, SF was more pronounced in the double transgenic animals. The percentage of the 40th fEPSP slope over the first during the tetanus was 18 -/+ 3% in APP/PS1 vs. 26 -/+ 2% in WT. Thus, it is likely that presynaptic mechanisms underlying SF but not PPF and PTP, may account for synaptic dysfunction in APP/PS1 mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974910     DOI: 10.2174/1567205053585936

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  11 in total

Review 1.  Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

Authors:  Nicholas M Kanaan; Gustavo F Pigino; Scott T Brady; Orly Lazarov; Lester I Binder; Gerardo A Morfini
Journal:  Exp Neurol       Date:  2012-06-19       Impact factor: 5.330

2.  A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics.

Authors:  Ulises M Ricoy; Peizhong Mao; Maria Manczak; P Hemachandra Reddy; Matthew E Frerking
Journal:  Neurosci Lett       Date:  2011-06-29       Impact factor: 3.046

Review 3.  Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer's Disease: a Review of Current Evidence.

Authors:  Niyaz Mohammadzadeh Honarvar; Ahmad Saedisomeolia; Mina Abdolahi; Amir Shayeganrad; Gholamreza Taheri Sangsari; Babak Hassanzadeh Rad; Gerald Muench
Journal:  J Mol Neurosci       Date:  2016-11-18       Impact factor: 3.444

Review 4.  Selected Micronutrients in Cognitive Decline Prevention and Therapy.

Authors:  Francesco Visioli; Emma Burgos-Ramos
Journal:  Mol Neurobiol       Date:  2015-07-22       Impact factor: 5.590

5.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

6.  Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.

Authors:  Matthew Townsend; Ganesh M Shankar; Tapan Mehta; Dominic M Walsh; Dennis J Selkoe
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

7.  Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.

Authors:  Hang Xing; Xiong Han; Sihan Xu; Zhongyu Sun; Shijun Yang
Journal:  J Mol Neurosci       Date:  2022-03-12       Impact factor: 3.444

Review 8.  Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders.

Authors:  Yogesh Kumar Dhuriya; Divakar Sharma
Journal:  J Mol Neurosci       Date:  2020-06-06       Impact factor: 3.444

9.  Age-dependent shift in the de novo proteome accompanies pathogenesis in an Alzheimer's disease mouse model.

Authors:  Megan K Elder; Hediye Erdjument-Bromage; Mauricio M Oliveira; Maggie Mamcarz; Thomas A Neubert; Eric Klann
Journal:  Commun Biol       Date:  2021-06-30

10.  Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.

Authors:  Siddhartha Mondragón-Rodríguez; George Perry; Xiongwei Zhu; Jannic Boehm
Journal:  Int J Alzheimers Dis       Date:  2012-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.